Production of monoclonal antibody specific to surface antigen on hepatocellular carcinoma cell lines
Liver cancer ranks fifth in frequency in the world and this disease tends to increase every year. HCC is a type of liver cancer which is the most severe. When there are signs and symptoms, it means poor prognosis. Patients always die within a few months after detecting the nodules. In general, HCC i...
Main Authors: | Pawaraid On-Tong, Preeyanat Vongchan |
---|---|
Format: | Article |
Language: | English |
Published: |
Chaing Mai University
2011-01-01
|
Series: | Journal of Associated Medical Sciences |
Subjects: | |
Online Access: | https://www.tci-thaijo.org/index.php/bulletinAMS/article/view/60048 |
Similar Items
-
Production of horseradish peroxidase conjugated monoclonal anti-heparan sulfate proteoglycans antibody for immunologic assay
by: Nittaya Chansiw, et al.
Published: (2008-09-01) -
Antibody-Drug Conjugates and Targeted Treatment Strategies for Hepatocellular Carcinoma: A Drug-Delivery Perspective
by: David Dahlgren, et al.
Published: (2020-06-01) -
Application of metabolomics in research on biomarkers for hepatocellular carcinoma
by: WANG Jiangang
Published: (2014-08-01) -
Development of FITC-conjugated monoclonal anti-human liver HSPGs, F(ab’)2 for the investigation of acute myeloid leukemia by directimmunofluorescent technique
by: Benchaporn Taweeapiradeechat, et al.
Published: (2009-05-01) -
Hepatocellular carcinoma. An overview
by: Daniel Motola-Kuba, et al.
Published: (2006-01-01)